Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03023930 · ClinicalTrials.gov registry record · NA
Opioid Use Disorder in the Emergency Department: CTN 0069
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 1,731
- Enrollment target
NCT03023930 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,731 participants.
The verdict
NCT03023930, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,731 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of (1) Implementation Facilitation (IF) on rates of provision of Emergency Department (ED)-initiated buprenorphine/naloxone (BUP) treatment with referral for ongoing medication-assisted treatment (MAT) and the (2) effectiveness of IF on patient engagement in formal addiction treatment at 30 days.
Interventions
- OTHER Standard Dissemination Practice
- OTHER Implementation Facilitation (IF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,731 participants |
| Start Date | 2017-04-03 |
| Est. Completion | 2022-04-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03023930
The ClinicalTrials.gov registry entry for NCT03023930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,731 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Dissemination Practice is the first listed.
NCT03023930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03023930 about?
NCT03023930 is a clinical study titled "Opioid Use Disorder in the Emergency Department: CTN 0069". The purpose of this study is to evaluate the impact of (1) Implementation Facilitation (IF) on rates of provision of Emergency Department (ED)-initiated buprenorphine/naloxone (BUP) treatment with referral for ongoing medication-assisted treatment (MAT) and the (2) effectiveness of IF on patient eng...
What is the current status of trial NCT03023930?
This trial is currently completed. It is a NA study. The enrollment target is 1,731 participants. The study started on 2017-04-03. Estimated completion is 2022-04-23.
What interventions are being tested in trial NCT03023930?
The interventions under investigation include: Standard Dissemination Practice (OTHER), Implementation Facilitation (IF) (OTHER).
Who is sponsoring clinical trial NCT03023930?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.